A | TRAIL | Â | |||
Untreated | 50Â ng/mL | 100Â ng/mL | ANOVA | ||
FCCP (μM) | Vehicle | 1.00 ± 0.08a | 1.00 ± 0.06a | 0.94 ± 0.07a | 0.7702 |
1.0 | 0.89 ± 0.03a,b | 0.72 ± 0.03b* | 0.74 ± 0.03a* | 0.009 | |
2.5 | 0.74 ± 0.03b,c | 0.67 ± 0.02b | 0.60 ± 0.02b* | 0.0233 | |
5.0 | 0.66 ± 0.02c | 0.58 ± 0.06b | 0.57 ± 0.05b | 0.3392 | |
ANOVA | Â | 0.0035 | 0.0009 | 0.002 | Â |
B | Cisplatin | Â | |||
Untreated | 1 μM | 10 μM | ANOVA | ||
FCCP (μM) | Vehicle | 1.00 ± 0.06a | 0.97 ± 0.13a | 1.11 ± 0.02a | 0.5124 |
1.0 | 0.89 ± 0.01a | 0.82 ± 0.10a | 0.85 ± 0.01b | 0.6946 | |
2.5 | 0.99 ± 0.09a | 0.78 ± 0.08a | 0.75 ± 0.01c | 0.0941 | |
5.0 | 0.90 ± 0.01a | 0.74 ± 0.10a | 0.78 ± 0.04b,c | 0.23 | |
ANOVA | Â | 0.3707 | 0.4635 | 7.78E-06 | Â |
C | TRAIL | Â | |||
Untreated | 50Â ng/mL | 100Â ng/mL | ANOVA | ||
Oligomycin (μM) | Vehicle | 1.00 ± 0.02a | 0.96 ± 0.14a | 1.08 ± 0.03a | 0.5539 |
1.0 | 1.37 ± 0.00b | 1.15 ± 0.07a | 1.26 ± 0.07a | 0.093 | |
2.5 | 1.38 ± 0.12b | 1.14 ± 0.15a | 1.31 ± 0.04a | 0.353 | |
5.0 | 1.36 ± 0.05b | 1.19 ± 0.16a | 1.25 ± 0.05a | 0.535 | |
ANOVA | Â | 0.0082 | 0.6272 | 0.0503 | Â |
D | Cisplatin | Â | |||
Untreated | 1 μM | 10 μM | ANOVA | ||
Oligomycin (μM) | Vehicle | 1.00 ± 0.01a | 0.99 ± 0.01a | 1.01 ± 0.02a | 0.6714 |
1.0 | 1.46 ± 0.18a,b | 1.29 ± 0.16a | 1.62 ± 0.03b | 0.3404 | |
2.5 | 1.83 ± 0.06b | 1.21 ± 0.04a** | 1.55 ± 0.09b,c* | 0.0014 | |
5.0 | 1.23 ± 0.08a | 1.10 ± 0.04a | 1.13 ± 0.02a | 0.2911 | |
ANOVA | Â | 0.003 | 0.1401 | 4.23E-05 | Â |